The regulator approved the indication based on data showing Kisqali with an aromatase inhibitor improved invasive disease-free survival versus just an aromatase inhibitor.

Cognitive dysfunction has been considered as a morbid condition that may possibly result from aromatase inhibitor therapy, the standard treatment in postmenopausal, estrogen/progesterone receptor ...

Aromatase inhibitors (AIs) are a class of drugs that block the aromatase enzyme, which is responsible for converting androgens (male hormones) into estrogens (female hormones). These medications ...

[5] Early adjuvant therapy -- replacing tamoxifen therapy with aromatase inhibitor therapy during the first 5 years after surgery; Early sequential adjuvant therapy -- sequencing of tamoxifen and ...

We read with interest the article by Marie Lund and colleagues published in The Lancet Oncology investigating the association between aromatase inhibitor treatment (AIT) and ischaemic cardiotoxicity ...

Department of Oncology, Zhujiang Hospital, Southern Medical University, Guangzhou, Guangdong 510282, China ...

Prescribing drugs "off-label" means that a healthcare provider has prescribed a medication that is approved by the Food and Drug Administration (FDA ... One study found that taking an estrogen blocker ...

The FDA also expanded the indication for metastatic disease: abemaciclib can now be used in combination with an aromatase inhibitor for the treatment of people with HR+, HER2- advanced or metastatic ...

Discover the role of phytoestrogens, including soy, in menopause management and breast cancer prevention. Learn how these ...

“Most foods are processed in some way, for example to enable preservation”, says Huntriss, “but the term ‘ultra-processed’ refers to foods that often have a long ingredients ...